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nociceptive neurones, and is reversible (see Sessle 199fii. 
The "central sensitization" processes expressed in V nociceptive 
pathways may involve NMDA receptor mechanisms since the 
mustard oil-evoked increase in jaw muscle activity and the expan-
sion of the neuronal mechanoreceptive field can he reduced by 
systemic or intracerebral application of the NMDA antagonist 
MK-SOl in a dose-dependent manner (Yu et al. 1996). A role for 
N M D A mechanisms in central V nociceptive processing is sup-
ported by other V neurophannacological and imnumohistochemi-
cal data (see Sessle 19961 and by analogous findings in spinal 
dorsal horn that are outlined in the three articles. It is also of 
interest that the local application of MK-SOl to TMJ tissues can 
block the mustard oil-evoked jaw muscle activity (Yu et al. 1996). 
These Findings are consistent with data indicating that NMDA 
receptors may be located in peripheral tissues ifor review, see 
Erdb 1991) and appear to be the first to document that NMDA 
antagonists may act peripherally to reduce a nociceptive reflex. 
Although the detailed mechanisms underlying such a peripheral 
action remain to be clarified, these findings do raise other poten-
tial approaches (e.g.. peripherally applied NMDA antagonists) for 
inducing pre-emptive analgesia in addition to those outlined by 
CODERRE & KATZ (sect. 5) and DICKENSON (sect. 4.3). 
Several other factors involved in the central sensitization pro-
cess in the spinal nociceptive system have been outlined by 
these three target articles. One of these involves endogenous 
opioids. Central opioids have also been shown to be important 
modulators of V nociceptive processing (see Sessle 1996). In-
deed. central opioids may be recruited to limit the duration and 
extent of central sensitization evoked by nociceptive barrages 
entering the CNS: once the jaw muscle and caudalis neuronal 
excitability increases induced by deep tissue injection (e.g., into 
TMJ) of mustard oil have dissipated (see above), the changes 
can be "rekindled" in a dose-dependent manner by administra-
tion of the opioid antagonist naloxone (Sessle 1996: Yu et al. 
1994). The finding that naloxone administration in animals re-
ceiving the TMJ injection of vehicle (mineral oil) does not in-
duce a recurrence of the increased muscle activity indicates that 
the increased activity is dependent on the previous occurrence 
of mustard oil-induced effects. Preliminary data (Tambeli et al., 
. . • unpublished) that the specific mu opioid receptor antagonist 
CTOP replicates these effects of naloxone suggest that a central 
mu-receptor opioid mechanism is triggered bv the mustard oil-
evoked afferent input and limits the increase in muscle activity 
and associated central sensitization. Our findings appear to be 
consistent with the concept of opioid recruitment mentioned by 
DICKENSON (sect. T.l) and by WIESENFELD-HALLIN e t al. 
(sect. 4) but may also have relevance to the opioid insensitivitv 
noted in these two articles since it is conceivable that central 
opioid dysfunction could result from prolonged opioid release 
induced by a sustained afferent barrage. Peripherally acting 
opioids such as those noted by DICKENSON (sect. 4.3) do not 
appear to be involved in these particular effects since the pe-
ripherally acting opioid antagonist methvlnaloxone does not 
block the mustard oil-evoked changes (Yu et al. 1994). 
Other neurochemical modulators have" also been discussed in 
these three target articles; WIESENFELD-HALLIN e t al. (sect. 3) 
especially emphasize the potential role of CABA mechanisms in 
central inhibitory mechanisms, dysfunction of which may lead to 
pain phenomena. In the V system, it is interesting in this light that 
the excrutiatingly painful condition of V neuralgia has allodynia-
like features in that it can be triggered by a light tactile perioral 
stimulus and controlled by the GABAb agonist baclofen which also 
affects central inhibition in V brainstem neurones (Fromm 1991). 
ute to alludvniu if there is dysfunction of central inhibitory mecha-
nisms. 
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Abstract: This commentary provides experimental (lata in support of the 
critical role of capsaiein-sensitive primary afferent fillers in the initiation 
and maintenance of pathological pain. The demonstration of capsaicin-
indnced. centrally-evoked cutaneous hyperalgesia, and of neuroplaxric 
clumges elicited by the defeneration of C-fiber primarv afferent terminals 
following peripheral nerve damage, indicates a significant contribution of 
capsaiein-sensitive sensory ganglion neurons in the development of patho-
logical pain conditions, [CODERRE & KATZ] 
In their target article, CODERRE & KATZ put forward the hypoth-
esis that both peripheral and central neural mechanisms contrib-
ute significantly to pathological pain. The present commentary 
provides experimental data in support of a critical role of 
capsaicin-sensitive primary afferent fibers in the initiation and 
maintenance of pathological pain. This particular class of neurons 
is a morphologically and neurochemicaily well-defined population 
of primary sensory neurons with a unique dual functional trait. 
They are involved in the transmission of nociceptive impulses 
evoked by noxious mechanical, thermal, and chemical stimuli, 
they mediate somatic and visceral reflexes ("afferent function"), 
and. through the release of sensory neuropeptides from their 
peripheral endings, they participate in local regulatory functions 
of the innervated tissues ("efferent" or "local regulatory" function: 
Holzer 1991: Jancsó 196S: Jancsó et al. 1977: Lembeck 19S3; 
Maggi & Meli 19SS; Szolcsányi 1984). The available experimental 
evidence indicates that this particular class of afferent neurons 
may be involved in both the initiation and maintenance of painful 
conditions. 
It has long been known that application of capsaicin to the 
human skin produces marked mechanical and thermal hyper-
algesia (Szolcsánvi 1977: Tóth-Kása et al. 19861 Simiiarlv. intra-
dermal injection of capsaicin has been shown to produce cutane-
ous hyperalgesia: the findings indicated that central sensitization 
may be responsible for mechanical allodynia after capsaicin (Si-
moné et al. 1991). Animal studies clearly demonstrate that central 
mechanisms are critically implicated in the initiation of mechani-
cal hyperalgesia. There is experimental evidence that mechanical 
hyperalgesia can also be elicited merely by stimulation of the 
central terminations of capsaicin-sensitive primary afferents. In-
jection of minute amounts of capsaicin into the subarachnoid 
space brings about a characteristic sequence of vascular and 
behavioral responses in the rat (Gamse et al. 19S4: Jancsó 19S1). 
Intracisternal injection of capsaicin in rats anesthetized with ether 
elicited an immediate, short-lived cutaneous vasodilatation (i.e., 
chemically evoked dorsal root vasodilatation) und. after the anes-
thesia wore off. protective wiping movements. Following this 
acute excitatory phase, a characteristic mechanical hyepralgesia 
developed: light touching of the skin or even the hairs evoked 
vigorous protective reflex movements. It was interesting to note 
that during this period, which lasts up to 30 min. the areas inner-
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vated by afferent nerves related to the affected medullary and 
spinal dorsal.hom areas proved completely insensitive to noxious 
chemical irritants, including capsaicin and zingerone (Jancsó 
19S1: unpublished observations). 
These findings strongly suggest that capsaicin-sensitive af-
ferents are essential in the initiation but not in the maintenance of 
mechanical hyperalgesia. In addition, the fact that the mechanical 
hyperalgesia produced by intracistemal capsaicin is associated 
with a deprivation of nociceptive afferent input to the dorsal h o m 
neurons, is in line with the suggestion bv CODERRE & KATZ that 
once hyperalgesia is established, it does not need to be maintained 
by inputs, from the periphery (sect. 2.3. para. 2). Further, neuro-
histological findings indicated an earlv degeneration of spinal and 
medullary primary afferent terminals (Jancsó 19S1) similar to that 
seen in peripheral nerve endings upon exposure to capsaicin at 
concentrations which causes die release of neuropeptide(s) from 
diem (Király et al. 1991). 
It may accordingly be proposed that central sensitization is 
produced by the release of sensory neuron-derived mediator(s) 
from peptidergic capsaicin-sensitive afferents. This is supported 
by electrophysiological findings that the sensitization of spinal 
dorsal horn cells is critically dependent on substance P released 
from capsaicin-sensitive primary afferent terminals (Dray et al. 
.««¿99-1Although further studies are needed to clarify this point. 
^¿Pte finding that intracistemal injection of capsaicin is associated 
with an immediate marked cutaneous vasodilatation may indicate 
that substance P and'or calcitonin gene-related peptide is likelv to 
be involved (Chalil 19SS). 
The possible morphological changes which may ensue after 
peripheral nerve damage in the central terminations of nocicep-
tive primary afferent fibers were not addressed bv CODERRE & 
KATZ. However, such changes have been shown to occur and 
capsaicin-sensitive afferents may also be significantly implicated 
in the development of pain induced by peripheral nerve damage. 
Recent findings indicate that peripheral nerve injuries result in 
a progressive, delayed transganglionic degeneration of C-fiber 
capsaicin-sensitive primary afferent fibers (Jancsó 1992; Jancsó & 
Ambrus 1994: Jancsó 6c Lawson 1990 ). This may involve the initial 
release of sensory neuropeptides and thereby contribute to the 
development of sensory disturbances which follow peripheral 
nerve damage. It has been suggested that substantial C-fiber 
afferent deafferentation creates favorable circumstances for struc-
tural neuroplastic changes to occur, resulting in a reorganization of 
spinal dorsal hom neuronal connections (Jancsó 1992). Recent 
findings lend support to this assumption. It has been shown that 
after both perineural treatment with capsaicin or peripheral nerve 
fkection. which result in massive transganglionic degeneration of 
flR-'-fiher primary afferent terminals ( |ancsó 1992: Jancsó 6c Am-
brus 1994: Jancsó 6c Lawson 199(1). extensive sprouting of pre-
sumed thick primary afferents occurs within the substantia gela-
tinosa. which is normally devoid of myelinated afferent terminals 
(Mannion et al. 1996: Wbolf et al. 1995). These profound struc-
tural neuroplastic changes are most prohablv initiated bv degener-
ative changes in capsaicin-sensitive afferents and. by altering the 
connectivity of dorsal hom neurons, mav contribute significantlv 
to the development of pathological pain after nerve injuries 
(Jancsó 1992: Woolfet al. 1995). 
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Abstract: The belief that women report more somatic complaints than 
men is not new. Many centuries B.C.. the Egyptians and the Greeks already 
made an association between female pains and hysteria, which is Greek for 
"wandering womb." Despite the commonly held belief that women are 
more sensitive to pain than men. the issue of sex differences in pain has 
received little attention from the scientific community in general. It is the 
merit of BERKLEY to draw our attention to this large gap in our scientific 
knowledge. 
Alas, our frailty is the cause, not we. For such as we 
are made of. such we be. 
William Shakespeare. Twelfth Sight 
As is convincingly shown in BERKLEYS target article, the human 
literature on sex differences in pain is equivocal, possibly as a 
consequence of the myriad factors that are operative. Indeed, for 
nearly every study reporting a sex difference, one can find another 
reporting none. Consider the following two striking examples. In 
two controlled studies (Bush etal. 1993and Fe ineeta l . 1991;both • 
cited by Berkley) on sex differences in response to experimental 
heat pain, the authors came to opposing conclusions. Although the 
experimental procedures used in the two studies were very.similar 
(and both groups have extensive experience with psychophysical 
testing procedures). Feine et al. found that women are more 
sensitive to experimental pain than men. whereas Bush et al. found 
no sex differences. A second example concerns the effectiveness of 
spinal cord stimulation (SCS) in the relief of chronic non-
malignant pain. Whereas North (1991) found a significantly better 
therapeutic result of SCS in female patients. Kupers et al. (1994) 
found that men responded better than women. 
This large variability in results should wam us against reacting 
with too much enthusiasm whenever a new sex difference is put 
forward. For example, in a recent study. Gear et al. (1996) found 
that kappa-opioids produce significantly greater analgesia in 
women than in men. In view of the above-mentioned inconsis-
tency in the results on sex-related differences in pain derived from 
different laboratories, this finding should be interpreted with 
caution and be replicated in other independent studies. 
Although in BERKLEY'S review not much attention was paid to 
animal stiulies on sex differences, here we find the same inconsis-
tency as in the human literature. For instance, some studies failed 
to show gender-related baseline differences in hot plate and tail-
flick tests and after intraperitonial injection of acetic acid: but 
other studies showed gender-related differences in tlie formalin 
test. Another example-: whereas some studies reported that female 
rats are more susceptible to the development of neuropathic pain 
after nerve constriction, others showed that after dorsal root 
section, male rats were more susceptible to the deafferentation 
pain syndrome. 
Despite the enormous variability of gender differences in pain 
in both clinical and experimental pain studies, the onlv constants 
seem to be: 
1. Clinical pain syndromes: there are significantlv more 
studies showing that women report a higher incidence of endoge-
nous pain compared to men than there are studies showing the 
opposite. 
2. Experimentally induced pain: studies either show that 
women rate e.vnerimentallv applied stimuli as mnr» painful or no 
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Abstract 
The effect of high affinity galanin antagonist M35 on neurogenic cutaneous vasodilatation has been studied in the pigeon using 
a Laser Doppler Imager. Cutaneous application of mustard oil or antidromic electrical stimulation of a cutaneous nerve produced 
a small increase in skin blood flow. Close arterial injection of M35 prior to chemical or electrical stimulation resulted in a marked 
augmentation of the vasodilatory response. This effect was abolished by chronic denervation. The results suggest a nerve-
mediated inhibitory effect of endogenous galanin on neurogenic cutaneous vasodilatation in the pigeon skin and provide the first 
experimental evidence for an inhibitory local regulatory function of cutaneous sensory nerves at least in the avian skin. © 1998 
Published by Elsevier Science Ireland Ltd. 
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In the mammalian skin stimulation of chemosensitive 
afferent fibres induces local vascular changes involving 
vasodilatation and plasma extravasation [1,2,12,13]. These 
responses are mediated by the release of neuropeptides, 
primarily substance P (SP) and calcitonin gene-related pep-
tide (CGRP) from stimulated C-fibre nerve endings [9]. 
Previous studies have shown that in avian species neither 
antidromic electrical stimulation of afferent nerves nor 
direct stimulation of sensory nerve endings produce similar 
vascular responses [15,16]. Dorsal root ganglion (DRG) 
neurons of pigeons and chickens contain CGRP and SP in 
a quantity similar to rats and other mammals [3,7,8], and 
these neuropeptides have also been demonstrated in small 
nerve fibres in the skin of the chicken [17]. Furthermore, 
intravasal application of tachykinins and CGRP increases 
skin blood flow in the chicken [17]. One possible explana-
tion for the lack of vascular responses in the avian skin after 
stimulation of afferent nerves may be an inappropriate 
release of peptides from stimulated fibres. Several peptides, 
including galanin, have been shown to inhibit the release of 
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tachykinins and CGRP from mammalian sensory fibres 
[6,20]. Recent findings demonstrating that in the pigeon 
approximately 20% of DRG neurons contain galanin-like 
immunoreactivity [8] support a possible modulatory role 
for galanin. Noteworthy, in mammals galanin is present 
only in less than 5% of DRG neurons [4,10.18]. Therefore, 
we assumed that in the pigeon skin endogenous galanin 
might inhibit the release of tachykinins and/or CGRP 
from sensory nerves and modulate the vascular effects of 
these peptides. To test this hypothesis, in the present experi-
ments we studied the effect of a high affinity galanin antago-
nist M35 [19] on cutaneous vascular responses elicited by 
mustard oil, or by antidromic electrical stimulation of a 
cutaneous nerve. 
The experiments were performed on 30 domestic 
pigeons, anaesthetized with an isoflurane-oxygen gas mix-
ture and kept at a constant body temperature of 40°C. The 
external iliac artery and vein were cannulated for measure-
ment of the mean arterial blood pressure and for continuous 
electrolyte infusion, respectively. The ulnar artery was can-
nulated for close arterial infusion of the galanin antagonist 
Galanin (l-13)-bradykinin (2-9) amide (M35. Neosystem) 
dissolved in saline. Cutaneous blood flux (SBF) was mea-
0304-3940/98/S19.00 © 1998 Published by Elsevier Science Ireland Ltd. All rights reserved 
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sured on the defeathered wing skin by a Laser Doppler 
Imager (LDI; Lisca Development;. Blood pressure values 
and LDI signals were recorded, stored, and analyzed by a 
computer program. In the first series of experiments M35 
(0.5, 1 and 5 nM) or its vehicle (0.9% saline) were injected 
20 min after surgery in a volume of 500 /il into the ulnar 
artery within 10 min. Sixteen consecutive LDI images of a 
standardized skin area of 225 mm" were recorded at 1 min 
intervals. After determination of the basal SBF value, a 
piece of filter paper (10 mm in diameter) moistened with 
5% mustard oil was placed onto the skin. In six cases the 
radial nerve serving the investigated skin area was trans-
ected on both sides 4 - 6 days before the experiments 
(chronic denervated group). In a second series of experi-
ments (n = 7) antidromic nerve stimulation was used to 
induce cutaneous vascular responses in animals pretreated 
with guanethidine (20 mg/kg s.c.) 1 day before the experi-
ment to prevent sympathetic vasoconstriction. The nervus 
cutaneous antebrachii lateralis was transected and the distal 
end placed on a pair of steel electrodes. Following the 
intraarterial (i.a.) infusion of 1 or 5 nM M35 or its vehicle, 
sequential LDI images were taken from a skin area of 50 
mm2 with a frequency of 8 per min for 8 min. After a control 
period of 1 min, nerve stimulation was started with rectan-
gular pulses of 10 Hz, 20 V and 0.5 ms for a period of 20 s. 
Values of SBF were determined by calculation of the 
average flux values of single images. To demonstrate the 
time course of skin perfusion, the relative changes of SBF 
were plotted as a function of time. The total blood flow 
elevation elicited by mustard oil application was determined 
by calculation of the area under the flux curve for the total 
time of measurement (15 min). 
Slow retrograde i.a. infusion (500 /xl/10 min) of either 
vehicle or low doses of M35 (0.5 and 1 nM) did not cause 
any change in SBF or blood pressure. In two animals a 
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Fig. 1. Effect of epicutaneous application of mustard oil on skin blood 
flow (SBF) in control ( • ) and M35 pretreated animals after I.a. infu-
sion of saline and 1 nM ( • ) or 5nM (A) M35, respectively. The bar 
indicates the period of mustard oil application. For clarity, SD values 
are shown only in one direction. 
Table 1 
Relative increases in skin blood flow induced by mustard oil applica-
tion in intact or chronically denervated skin 
Control 1 nM M35 5 nM M35 
Intact skin 15.27 ± 5.34 29.74 ± 9.68* 40.4 ± 13.07* 
Denervated skin 16.12 ± 7.97 19.09 r 7.59 20.68 - 7 . 8 1 
Data are the mean ± SD of increases In skin blood flow (per cent) 
following mustard oil application on intact or chronically denervated 
skin in control and M35 pretreated animals from five to seven experi-
ments. 'Significantly different from control, P < 0.05. 
higher dose of M35 (5 nM) produced a slight decrease in 
blood pressure without any effect on SBF. Epicutaneous 
application of mustard oil after an i.a. infusion of 0.9% 
NaCl resulted in a slight increase in SBF (Fig. 1 and 
Table 1). After i.a. infusion of 1 or 5 nM M35, mustard 
oil elicited a marked dose-dependent increase in SBF 
(Fig. 1). Statistical evaluation of the data with one way 
ANOVA indicated a significant difference between the 
three groups (P = 0.01), while the post-hoc analysis (Stu-
dent-Newman-Keuls) revealed significant differences bet-
ween control and M35 pretreated groups. Mustard oil 
induced a similar small increase of SBF in normal and 
chronically denervated skin. In contrast, the effect of M35 
was significantly attenuated in the denervated skin: the mus-
tard oil induced vasodilatation was significantly smaller 
than the flux elevation measured in the intact skin after 
administration of M35 (Table 1). The two-way ANOVA 
confirmed the interaction between the effects of M35 pre-
treatment and denervation. 
The galanin antagonist also affected the cutaneous vasor-
eaction to antidromic nerve stimulation. In animals without 
guanethidine pretreatment, antidromic nerve stimulation 
resulted in a marked decrease in SBF, most probably due 
to the activation of sympathetic efferents. Pretreatment with 
guanethidine completely prevented this effect, unmasking a 
slight increase in SBF lasting for about 70 s. This small 
vasoreaction was not affected by i.a. infusion of 0.9% sal-
ine, but was changed markedly after M35 pretreatment (Fig. 
2). 
After infusion of 1 nM M35. antidromic nerve stimula-
tion caused an immediate short increase in SBF which was 
followed by a long lasting second elevation after a latency 
of about 90 s. This biphasic flux response turned into an 
immediate monophasic increase of SBF with a long plateau 
after pretreatment with 5 nM M35 (Fig. 2 and Table 2). 
The present experiments furnish evidence for the exis-
tence of neurogenic cutaneous vasodilator responses in the 
pigeon. Application of mustard oil onto the skin elicits a 
weak vasodilatory response which was not affected by 
denervation, indicating that this reaction is not of neuro-
genic origin. A similar non-neurogenic phlogogenic effect 
of mustard oil has been shown in the rabbit [14] and pig skin 
[11]. The vasodilatory effect of mustard oil was greatly 
enhanced by close arterial- administration of the specific 
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galanin antagonist M35. The effect of the galanin antagonist 
was almost completely abolished by chronic denervation of 
the skin. These results strongly indicate that the augmenta-
tion of the vasodilatory action of mustard oil by pretreat-
ment with the galanin antagonist is dependent on an intact 
cutaneous innervation. In addition, we obtained direct evi-
dence for a neurogenic vasodilator mechanism in the skin of 
the pigeon by showing that the slight increase in SBF result-
ing from antidromic stimulation of a cutaneous nerve was 
significantly enhanced by prior administration of the galanin 
antagonist. These observations indicate that neurogenic 
vasodilatory responses elicited either chemically or by anti-
dromic electrical stimulation of a cutaneous nerve in the 
skin of pigeons are under the inhibitory influence of endo-
genous galanin. The results also suggest that sensory nerves 
are intimately involved in this mechanism. It is tempting to 
suggest that in the intact (innervated) skin galanin may exert 
an inhibitory influence on the release of vasodilator sensory 
neuropeptides. Further studies are needed to clarify the pos-
sible source of galanin and the factors which influence its 
release. Since the primary aim of the present study was to 
reveal a presumed local regulatory or sensory efferent func-
tion of sensory nerves in an avian species, no attempt has 
been made to identify the possible mediator(s) of the 
observed vasodilatory effect. It can be suggested, however, 
that tachykinins and/or CGRP may be involved in this 
response. These peptides have been localized in avian dorsal 
root ganglion neurons [3,7,8] and cutaneous nerve fibres 
[17]. In addition, SP and CGRP showed potent vasodilator 
effects in the chicken skin [17], Further experiments utiliz-
ing specific peptide antagonists and/or immunoblockade 
may clarify this point. 
The present findings point to a new type of modulation of 
cutaneous inflammatory responses which may operate at the 
level of the sensory nerve ending by the release of inhibitory 
peptides. The results indicate that galanin may represent 
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Fig. 2. Effect of antidromic nerve stimulation on the skin blood flow 
(SBF) in control animals (i.a. infusion of 0.9% NaCI, O) and after 
infusion of 1 nM ( • ) or 5 nM M35 (A). The bar indicates the period 
of stimulation. 
Table 2 
Maximal increases in skin blood flow induced by antidromic nerve 
stimulation in control and M35 pretreated animals 
Time (min post- Control 1 nM M35 5 nM M35 
stimulation) 
0 -1 5.15 ±5.61 9.91 ± 1.22 12.6 ±1.78" 
1 -5 1.16 ± 3.44 10.99 ± 2.77* 13.79 ± 1.59* 
6 - 7 -0.59 ±3.11 3.63 ±5 .15 6.88 ± 4.33* 
Data are the mean ± SD of maximal increases in skin blood flow (per 
cent) measured for three different consecutive periods after the start 
of antidromic nerve stimulation (0 min) from five to seven experi-
ments. 'Significantly different from control, P < 0.05. 
such an endogenous peptide modulator. This assumption 
is in line with previous findings showing an inhibitory effect 
of exogenous galanin on neurogenic inflammatory reactions 
of the skin and joints [6,20]. It has been suggested that 
galanin is a potent endogenous inhibitor of neurogenic 
inflammation [6] and that the inhibitory effect of galanin 
may be due to an inhibition of the release of vasoactive 
peptides from sensory nerve terminals [5,6]. Although inhi-
bition of the release of neural vasoactive mediators by gala-
nin seems to be the most likely explanation for the effect 
observed in the present study, an interaction of galanin with 
vascular/endothelial mechanisms cannot be excluded. 
In conclusion, the present study revealed that in the 
pigeon antidromic electrical stimulation of a cutaneous 
nerve or direct application of a chemical irritant onto the 
skin evoke neurogenic vasodilatory responses which may be 
masked by an inhibitory action of endogenous galanin-like 
substance(s). The observations provide the first evidence 
that sensory nerves may be implicated in an inhibitory 
local regulatory function in the avian skin. 
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Abstract 
The possible role of endogenous galanin in modulation of cutaneous vascular responses was studied in pigeons. 
Chemically induced plasma extravasation and regional skin blood flow changes were measured simultaneously with a 
capillary perfusion technique and a laser Doppler imager, respectively. Perfusion with both histamine and bradykinin 
increased plasma protein extravasation which was dose-dependently and significantly augmented by co-administration 
of M35, a specific galanin antagonist. This effect of M35 was abolished after chronic cutaneous denervation. In intact but 
not denervated skin, M35 increased the vasodilatator effect of histamine, too. It is suggested that galanin-containing 
nerves may play an inhibitory efferent role in the modulation of cutaneous inflammatory responses. ©1999 Elsevier 
Science Ireland Ltd. All rights reserved. 
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In mammalian skin stimulation of chemosensitive affer-
ent fibres induces local vascular changes involving vasodi-
latation and plasma extravasation [3,10,12,15]. These 
responses are mediated by the release of neuropeptides, 
primarily tachykinins and calcitonin gene related-peptide, 
from stimulated nerve terminals [3]. Previous studies have 
shown that in avian species antidromic electrical stimulation 
of cutaneous nerves or direct chemical stimulation of 
sensory nerve endings produced only moderate vascular 
responses [4,16]. Immunohistochemical studies revealed 
that in birds, similar to mammals, dorsal root ganglion 
neurones of pigeons contain substance-P and CGRP 
[7,16]. However, it has been demonstrated also that, in the 
pigeon, the proportion of galanin-immunoreactive cells is 
considerably higher compared to mammals [8]. Exogenous 
galanin has been shown to inhibit neurogenic inflammatory 
processes in rats [6,20] and available experimental evidence 
indicates that endogenous galanin of neural origin inhibits 
neurogenic cutaneous vasodilatation in the pigeon [17]. 
Therefore, we assumed that the failure of chemical irritants 
to produce neurogenic vascular responses in the avian skin 
may be related to an inhibitory action of endogenous gala-
* Corresponding author. Tel.: +36-62-455-099; fax: +36-62-
455-842. 
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nin. To test this hypothesis, in the present experiments we 
studied the effect of a specific galanin antagonist on chemi-
cally-induced cutaneous vascular responses in the pigeon. 
The experiments were performed on 46 domestic pigeons 
(Columba livia) anaesthetised with an isoflurane-oxygen 
gas mixture. The dorsal surface of the wing was defeathered 
one day prior to the experiments. Mean arterial blood pres-
sure and body temperature were continuously monitored. 
Plasmapheresis capillaries (diameter: 0.4 mm, cut off size: 
3000 kDa, Asahi, Japan) were inserted intracutaneously 
with the aid of a guiding cannula and connected through a 
fine tubing (Tygon, Novodirekt, Germany) to a perfusion 
pump. The capillaries were perfused with Ringer's solution 
at a flow rate of 3.25 p.l/min. Fractions of the effluent were 
collected every 20 min for the determination of their protein 
content with Bradford's method [2] using an MRX micro-
titer-plate reader (Dynatech. Germany). After an equilibra-
tion period of 60 min, histamine (Sigma) or bradykinin 
(Neosystem) dissolved in Ringer's solution were perfused 
through the capillaries for 40 min. M35, a specific galanin 
antagonist (galanin-l-16-bradykinin-2-9-amide [1], Neo-
system) was co-perfused with bradykinin or histamine to 
examine their effect on plasma protein extravasation and 
vasodilatation evoked by these vasoactive agents. Cuta-
neous blood flow was measured with a laser Doppler imager 
(LDI, Moor Instruments). Consecutive perfusion images 
I. All rights reserved. 
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Fig. 1. Effect of M35, a specific galanin antagonist on plasma 
protein extravasation induced by histamine (500 p.M/1, black 
columns) and bradykinln (200 p.M/1, gray columns) in the Inner-
vated and denervated skin of the pigeon. Values are expressed 
as percentage Increases (mean ± SEM) In total protein content of 
the perfusate. 
were captured of a skin area of 0.6 cm 2 with a frequency of 
1/min. Photographic and perfusion images were processed 
as described previously [17]. To study the role of cutaneous 
nerves in the mechanism of cutaneous vascular responses 
elicited by these agents, the skin was denervated by section-
ing the ulnar and radial nerves 5 - 7 days before the experi-
ment. 
Perfusion of the skin with Ringer 's solution resulted in a 
gradual decrease of protein concentration of the perfusate. 
Pilot experiments showed that histamine and bradykinin 
produced dose-dependent increases in the plasma protein 
content of the perfusate (data not shown). In further experi-
ments concentrations of 200 and 500 |i,M/l of bradykinin 
and histamine, respectively, were chosen which produced 
similar and reproducible increases in cutaneous vascular 
permeability. The maximal increases of the protein content 
of the perfusate induced by histamine and bradykinin 
amounted to 2 8 2 ± 2 2 and 2 3 3 ± 1 8 p-g/mi. respectively. 
The calculated total protein content of the fractions 
collected for 60 min after the start of the perfusion were 
significantly higher after the administration of either hista-
mine (48 .65±3.36 mg) or bradykinin (43.73±3.36 mg), as 
compared with the control, i.e. infusion of Ringer's solution 
(20.91 ±1 .29 mg). Co-administration of increasing doses of 
the galanin antagonist, M35 caused dose-dependent 
increases in histamine-induced plasma protein extravasation 
(Fig. 1). Similarly, co-perfusion of M35 with bradykinin 
dose-dependently enhanced the protein content of the perfu-
sate. Calculation of the total protein content of the perfu-
sates collected for a 60-min period after co-administration 
of M35 showed significant dose- and drug-dependent 
increases for both histamine and bradykinin (two-way 
ANOVA P < 0 ,001; post-hoc analysis with Fisher LSD 
method P < 0.05). In contrast, in the chronically denervated 
skin co-administration of M35 failed to affect the responses 
to either histamine or bradykinin (Fig. 1). 
Both histamine and bradykinin produced significant 
increases in cutaneous blood flow as measured by LDI, 
although bradykinin produced a less marked effect. Co-
administration of M35 resulted in moderate increases in 
the vasod i l a t a to r response to both agents which reached 
significance in the case of histamine but not bradykinin 
(Fig. 2). Denervation markedly reduced the vasodi la ta tor 
effect of histamine but failed to significantly affect the 
response to bradykinin. The pro-vasodilatator effect of 
M35 on histamine-induced vasodilatation was completely 
abolished in the chronically denervated skin (Fig. 2). 
Mediators of the acute in f l ammator reaction may 
produce their vascular effects not only by a direct action 
on vascular smooth muscle or endothelium, but also by an 
action on cutaneous nerves [3,9,11]. The release of s e n s o r 
neuropeptides by bradykinin and histamine [3,5] signifi-
cantly contributes to the permeability-enhancing effect of 
these agents [9,11]. Hence, the reduction of the vasodilata-
t o r effect of histamine observed in the present experiments 
following denervation may be accounted for by a lack of 
release of vasodi la ta tor peptide(s) from cutaneous nerves. 
Denervation failed to affect the vasodi la ta tor effect of 
bradykinin which, therefore, may be attributed mostly to a 
direct action on vascular smooth muscle under the experi-
mental conditions used. 
The most striking observation of the present study was the 
marked increase of the vasodilatator a n d- in particular, the 
vascular permeability enhancing effects of both histamine 
and bradykinin after the administration of M35. a specific 
galanin antagonist. This may suggest that release of vasoac-
tive peptides f rom cutaneous nerves may be under a tonic 
galaninergic inhibition in this species. Several line of 
evidence support this suggestion. Exogenous galanin is 
known to inhibit the release of in f l ammator neuropeptides 
2 50 
2 40 
m 
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+ M35 
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Fig. 2. Effect of M35, a specific galanin antagonist on cutaneous 
vasodilatation elicited by histamine (500 jiM/l) and bradykinin 
(200 p.M/1) In the innervated (black columns) and denervated 
(gray columns) skin of the pigeon. 
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from sensory nerves [6,20]. Furthermore, inhibition of the 
release of a number of classical and peptide transmitters and 
hormones by galanin is well documented [13]. Finally, gala-
nin receptors were demonstrated on primary sensory 
neurons of several species [18,19]. In conclusion, the 
present findings strongly indicate that galanin-containing 
nerves may fulfil a novel, inhibitory sensory-efferent func-
tion of cutaneous nerves. The widespread presence of gala-
nin in sensory fibres of the rat may indicate that similar 
mechanisms may operate in species other than the pigeon 
[14]. Further studies are needed to determine the factors 
which may influence and modify the release of peptides 
and/or other mediators from cutaneous nerves or non-neural 
elements under physiological conditions. 
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Noxious stimulation induces local inflammatory responses in a variety of mammals but 
these reactions are only faint in avian species. The possibility that endogenous galanin inhibits 
neurogenic vascular responses in avians was tested in the wing skin of anaesthetized pigeons. 
Intraarterial infusion of nanomolar concentrations of the specific galanin antagonist M35 dose 
dependently enhanced the small mustard oil induced increase of skin blood flow measured by 
means of a Laser Doppler Imager. Similarly, the small transient vasodilatation following electrical 
stimulation of a cutaneous nerve was also enhanced by M35. The effect of M35 was not observed 
after chronic denervation. Coperfusion of M35 dose dependently augmented the histamine and 
bradykinin induced plasma extravasation revealed by skin microdialyses, but this effect was 
abolished in the chronically denervated skin. However, chronic denervation per se enhanced the 
plasma extravasation induced by histamine but not by bradykinin and this effect was diminished 
by coperfusion of galanin. The results suggest an inhibitory modulation of cutaneous neurogenic 
inflammatory reactions by endogenous galanin in the pigeon. 
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species, galanin antagonist M 35, cutaneous nerve, histamine, bradykinin, pigeon 
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A significant population of mammalian cutaneous afferent nerves involved in the 
transmission of noxious information also possesses local regulatory or "sensory 
efferent" functions. Sensory nerve-mediated neurogenic inflammatory responses such as 
involving vasodilatation and plasma protein extravasation are the most prominent 
features of sensory efferent functions. These tissue reactions are mediated primarily by 
tachykinins and calcitonin gene-related peptide (CGRP) released from stimulated 
sensory nerve terminals. In addition, a modulatory, pro-inflammatory effect of these 
sensory neuropeptides has also been documented [6]. In contrast to mammals, 
neurogenic inflammatory responses are only moderately expressed in avian species [3, 
8]. This species difference cannot be explained by an inappropriate level of sensory 
neuropeptides. Immuno-histochemical studies revealed that avian dorsal root ganglion 
neurones contain tachykinins and CGRP similar to mammalian sensory cells [5, 8]. 
However, in pigeon dorsal root ganglia the proportion of galanin-immunoreactive 
neurones is considerably higher than in mammals [5]. Previous studies have shown that 
exogenous galanin inhibited neurogenic inflammatory reactions in the rat by inhibition 
of peptide release from afferent nerves [4, 10]. We hypothesised that in the pigeon 
endogenous galanin may interfere with the effect of sensory neuropeptides or 
inflammatory mediators leading to a reduction of their vascular actions. To test this 
hypothesis, in the present experiments we studied the effect of a specific galanin 
antagonist on sensory nerve-mediated cutaneous vascular responses. 
Materials and methods 
Experiments were performed on 76 domestic pigeons anaesthetised with an 
isoflurane-oxygen gas mixture. The dorsal surface of the wing was defeathered one day 
prior to the experiments. The arterial blood pressure and the body temperature were 
continuously monitored. In 30 animals the ulnar artery was canulated for close arterial 
injection of galanin antagonist (galanin (1-13) - bradykinin (2-9) amide, M35, 
Neosystem) dissolved in physiological saline. Skin blood flux (SBF) was measured on 
the defeathered wing skin by a Laser Doppler Imager (LDI). In the first series of 
experiments different doses of M35 and its vehicle were administered into the ulnar 
artery (50 |il/min). Sixteen consecutive LDI images were recorded from a standardised 
skin area at 1 min intervals. After determination of the baseline perfusion a piece of 
filter paper moistened with 5% mustard oil dissolved in liquid paraffin was placed onto 
the skin. In 6 cases the radial nerve innervating the investigated skin area was transected 
4-6 days before the experiments (chronic denervation). In the second series of 
experiments antidromic nerve stimulation was used to elicit cutaneous vascular 
responses in guanethidin pretreated animals (20mg/kg s.c.). The nervus cutaneous 
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antebrachii lateralis was exposed for electrical nerve stimulation. Following an intra-
arterial infusion of M35 or its vehicle sequential LDI images were taken with a 
frequency of 8/min for 8 min. Nerve stimulation was started after the 1st min with 
rectangular pulses of 10 Hz, 20 V and 0.5 ms for 20 s. Values of SBF were determined 
by calculation of the average flux values of single images. For a detailed description of 
the data analysis see reference [9]. Statistical analysis of the experimental data was 
performed with ANOVA. 
In 46 animals plasmapheresis capillaries (diameter 0.4 mms, cut off size 300 kDa, 
Asahi Japan) were inserted intracutaneous ly with the aid of a guiding cannula and 
connected through fine plastic tubes (Tygon) to a perfusion pump. The capillaries were 
perfused with Ringer's solution at a flow rate of 3.25 pl/min. The effluent fractions 
were collected every 20 min for photometric determination of their protein content 
using Bradford's method [2]. After a 60 min equilibration period histamine or 
bradykinin dissolved in Ringer's solution were perfused for 40 min. To study a possible 
modulatory role of galanin on cutaneous vasodilatation and plasma extravasation the 
galanin antagonist M35 was co-perfused with histamine and bradykinin. SBF was 
measured with LDI as described above. To study the contribution of nervous elements 
to the mechanism of inflammatory responses chronic cutaneous denervation was 
produced by sectioning the radial and ulnar nerves 5-7 days prior to the experiments. 
Results 
Epicutaneous application of mustard oil induced a slight increase in SBF (15.27± 
2.39%). Intraarterial infusion of 1 or 5 nM M35 significantly and dose-dependently 
increased mustard oil-induced enhancement of SBF (1 nM : 29.74±4.33% and 5 nM : 
40.4±5.85%) calculated by the area under the curve method (Fig. 1). Neither infusion of 
vehicle nor infusion of 5 nM M35 alone altered significantly the SBF. In the chronically 
denervated skin, mustard oil evoked responses similar to that was seen in intact skin 
(16.12±3.56%). In contrast, administration of M35 failed to result in an enhancement of 
mustard oil-induced cutaneous vasodilatation (Fig. 1). 
Antidromic electrical stimulation of the cutaneous antebrachii lateralis nerve with 
a short train of suprathreshold impulses elicited a transient increase in SBF (max. 5.15± 
2.51%) in guanethidin pretreated animals. Intraarterial infusion of 1 nM M35 resulted in 
an increase of the immediate vasodilatator response (9.91±1.22%) followed by a 
further increase in the SBF (10.99+1.24%) after a latency of 60s. Infusion of 5 nM M35 
produced a further enhancement (13.79+0.71%) of these vasodilatator responses. 
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To elicit plasma extravasation, histamine and bradykinin were perfused at 
constant doses of 500 and 200 pM/1, respectively, which have been shown to produce 
similar and reproducible increases in vascular permeability. The calculated protein 
content of the fractions collected during a 60 min period following the start of the 
perfusion of histamine and bradykinin amounted to 48.65+3.36 pg and 43.73±3.36 pg, 
respectively, which were significantly higher than compared to the control values 
obtained after perfusion of Ringer's solution (20.91+1.29 pg). Co-administration of 
increasing doses (2 and 10 pM/1) of M35 dose-dependently enhanced the permeability 
increasing effects both of histamine and bradykinin by 63% and 48%, respectively 
(Fig. 2). 
Chronic denervation per se significantly enhanced the permeability increasing 
effect of histamine but was without effect on the action of bradykinin. Co-perfusion of 
galanin (10pM/l) reduced this augmented response following histamine application. 
Co-administration of M35 failed to affect significantly the permeability increasing effect 
of either histamine or bradykinin (Fig. 2). 
Perfusion of both histamine and bradykinin increased cutaneous blood flow by 
28.43±4.19% and 22.04±2.9%. Co-administration of M35 significantly augmented the 
vasodilatator effect of histamine (SBF increase: 40.92+6.25%) but not that of 
bradykinin (26.41±4.82%). Chronic denervation reduced the vasodilatation elicited by 
histamine (17.81+5.33%) but failed to affect the response to bradykinin (21.2+3.7%). 
However, in the chronically denervated skin M35 was without any effect on irritant 
induced vasodilatation (histamine: 19.32+3.1%; bradykinin: 22.62±3.23%). 
Discussion 
Neurogenic cutaneous vascular responses elicited by chemical irritants and 
mediated by activation of afferent nerves are common in mammalian species. In 
contrast, in the pigeon only moderate vascular responses were evoked by epicutaneous 
application of mustard oil in the present study. This weak vasodilatator response was 
greatly augmented by a prior close arterial injection of M35, a high affinity galanin 
antagonist. Similarly, the modest cutaneous vasodilatation produced by antidromic 
nerve stimulation was also significantly enhanced after the administration of the galanin 
antagonist. These findings strongly indicate that endogenous galanin exerts a tonic 
inhibitory action on sensory nerve-mediated cutaneous vasodilatation. Furthermore, the 
findings showing an abolition of the pro-inflammatory effect of the galanin antagonist in 
the chronically denervated skin suggest that inhibitory modulation of the vasodilatator 
response by galanin is neurogenic in nature. 
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Histamine and bradykinin produced distinct plasma protein extravasation in the 
pigeon skin. The amount of extravasated plasma protein was greatly increased after a 
prior administration of M35. These results suggest that endogenous galanin may exert 
an inhibitory effect on histamine- and bradykinin-evoked increases in vascular 
permeability. In the chronically denervated skin administration of M35 was without 
effect on histamine or bradykinin elicited vascular responses. This suggests that the 
inhibitory modulation of the permeability enhancing effects of these vasoactive agents 
involves a neurogenic link. It is worthy to mention that chronic denervation resulted in a 
marked augmentation of the vascular permeability enhancing effect of histamine but not 
bradykinin. This may be explained by a possible difference in the (neural) regulation of 
vascular histamine and bradykinin receptors, respectively. Alternatively, these changes 
may be related to denervation-induced alterations in the prejunctional modulation of 
histamine-induced neuropeptide release from sensory nerves [7]. 
In conclusion, the present experiments revealed a marked inhibitory modulation 
of cutaneous vascular responses involving neurogenic vasodilatation and plasma 
extravasation by endogenous galanin. The results provide evidence for a new, hitherto 
unrecognized inhibitory local efferent function of peptidergic cutaneous sensory nerves. 
Inhibition of peptide release from sensory nerves by endogenous agents, e.g. by galanin, 
may explain the inability of chemical irritants or antidromic nerve stimulation to evoke 
sensory nerve-mediated neurogenic vascular responses in species other than small 
laboratory rodents. 
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Abstract 
The neurohumoral modulation of the permeability increasing effect of histamine was studied in pigeon skin. Substances were 
administered through plasmapheresis capillaries inserted into the dorsal wing skin and the protein contents of the perfusates were 
determined by a quantitative method. The vascular labelling technique was also utilized to histologically identify leaky blood vessels. In 
the innervated skin histamine evoked a significant, dose-dependent plasma extravasation which was markedly augmented by the 
coadministration of a specific galanin receptor antagonist, galanin-l-l6-bradykinin-2-9-amide (M35). Chronic cutaneous denervation per 
se resulted in a significant elevation of the permeability-enhancing effect of histamine. In the denervated skin this response was not 
affected by M35 but was significantly inhibited by galanin. It is concluded that in the normally innervated skin endogenous galanin may 
exert a neurogenic tonic inhibitory effect on histamine-induced plasma leakage. It is suggested that sensory nerves possess not only 
pro-inflammatory, but also anti-inflammatory (inhibitory) sensory-efferent functions. © 2000 Elsevier Science B.V. All rights reserved. 
Keywords: Skin; Inflammation; Galanin; Sensoty; Vascular labelling 
1. Introduction 
Histamine is a major mediator of inflammatory reactions 
and plays an important role in cutaneous vascular re-
sponses. Humoral and neural influences may effectively 
modulate the permeability enhancing effects of a variety of 
vasoactive agents involving histamine. In particular, selec-
tive sensory denervation has been shown to markedly and 
significantly inhibit cutaneous dye leakage responses 
evoked by histamine [1-4], The pro-inflammatory action 
of sensory nerves has been attributed to a release of 
vasoactive peptides from sensory nerve endings upon 
stimulation by inflammatory mediators resulting in an 
amplification of the primary response [2,3,5,6]. The sen-
sory-efferent or local regulatory function of sensory nerves 
'Corresponding author. 
E-mail address: jancso@phys.szote.u-szeged.hu (G. Jancsó). 
accomplished by the release of vasoactive sensory neuro-
peptides is well established in several mammalian species 
[7-9]. Similar sensory nerve-mediated cutaneous re-
sponses could not be demonstrated in avian species [10]. 
However, recent findings have shown that following the 
administration of a specific galanin receptor antagonist, 
electrical or chemical stimulation of cutaneous sensory 
nerves also elicited neurogenic vasodilatation and plasma 
extravasation in the pigeon [11,12]. The available ex-
perimental evidence indicated that the release of sensory 
neuropeptides may be under a tonic galaninergic inhibition 
in this species. This galanin-mediated modulation is neuro-
genic in nature, since chronic cutaneous denervation 
completely eliminated the effect of the galanin antagonist. 
Therefore, it has been concluded that sensory nerves may 
exert not only pro-inflammatory (stimulatory) but also 
inhibitory sensory-efferent functions [12]. The present 
experiments were initiated in an attempt to characterize the 
0167-0115/00/S - see front matter © 2000 Elsevier Science B.V. All rights reserved. 
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79 (inhibitory) modulatory action of cutaneous sensory nerves 
80 on histamine-induced plasma extravasation in the pigeon. 
Statistical evaluation of the experimental data was per- 13! 
formed using ANOVA. 132 
2. Materials and methods 
Forty-six domestic pigeons (Columba livia) anaesthet-
ised with an isoilurane-oxygen gas mixture were used in 
these experiments. The feathers covering the dorsal surface 
of the wing were removed the day before the experiment. 
The femoral artery and vein were cannulated for recording 
of the mean arterial blood pressure and intravenous 
injections. Body temperature was continuously monitored 
and maintained at 39±1°C. Plasmapheresis capillaries 
(diameter: 0.4 mm, cut-off size: 3000 kDa, Asahi, Japan) 
were inserted intracutaneously with the aid of a guiding 
cannula and connected through a fine tubing (Tygon, 
Novodirekt, Germany) to a perfusion pump. The capil-
laries were perfused with Ringer's solution at a flow-rate 
of 3.23 ml/min. Fractions of the effluent were collected 
every 20 min for the determination of their protein content 
with Bradford's method [13] using an MRX microplate 
reader (Dynatech, Germany). After an equilibration period 
of 60 min, histamine (Sigma) dissolved in Ringer's 
solution was perfused through the capillaries for 40 min. 
Porcine galanin (Neosystem) or the specific galanin an-
tagonist, M35 (galanin-l-16-bradykinin-2-9-amide, 
Neosystem [14]) were co-perfused with histamine to 
examine its effect on plasma protein extravasation. To 
study the role of cutaneous nerves in the mechanism of 
histamine-induced plasma extravasation and of the effects 
of the galanin antagonist, cutaneous denervation was 
performed by sectioning the ulnar and radial nerves 5 - 7 
days before the experiment. 
To demonstrate the vascular changes associated with 
increased permeability, the vascular labelling technique 
[13-17] was used for the histological visualization of the 
distribution and type(s) of leaky blood vessels in the intact 
(innervated) and denervated wing skin. Briefly, different 
doses of histamine (1 or 10 pg per site) were injected 
intracutaneously 10 min after injections (100 pi) of 
Tyrode's solution or M35 (5 or 10 pM) at the same sites. 
Immediately after the injection of histamine, infusion of a 
1% solution of colloidal silver (1 ml/100 g b.w.) was 
started at a rate of 0.5 ml/min. The animals were sacrificed 
20 min later by an overdose of the anaesthetic and skin 
samples were removed and processed for histological 
examination as whole mounts [2,16]. The density of leaky 
blood vessels was determined by measuring the lengths of 
silver-labelled vessels with the aid of a camera lucida and 
a digitizing tablet using a computer program (SIGMA-SCAN). 
Values are expressed as the length of the labelled blood 
vessels per unit skin area (mm/mm2). Diameters of silver-
labelled blood vessels were measured using an ocularmic-
rometer. All values are expressed as mean±S.E.M. 
3. Results 133 
Perfusion of Ringer's solution through intracutaneously 134 
placed plasmapheresis capillaries resulted in a gradual 135 
decrease of protein concentration of the perfusate reaching ¡36 
a low constant level after 40 min. The effective doses of ¡37 
histamine in inducing plasma protein extravasation were 138 
determined in pilot experiments. Increasing doses of 139 
histamine evoked a dose-dependent increase in vascular 140 
permeability as determined on the basis of the maximal 141 
(peak) increases in the protein content of the perfusates 142 
(data not shown) or by calculating the total amount of 143 
extravasated protein following a 40-min period of his- 144 
tamine application (Table 1). 145 
In further experiments a histamine concentration of 500 146 
pM was chosen which produced marked plasma protein 147 
extravasation. The calculated total protein content of the 148 
fractions collected for 60 min after the start of the 149 
perfusion were significantly higher after the administration 150 
of histamine (48.65+3.36 pg) as compared to the control 151 
i.e. infusion of Ringer's solution (20.91±1.29 pg). Coad- 152 
ministration of increasing doses of the galanin antagonist, 153 
M35 caused dose-dependent increases in histamine-in- 154 
duced plasma protein extravasation. Calculation of the 155 
total protein content of the perfusates collected for a 156 
60-min period after coadministration of histamine and M35 157 
showed significant dose- and drug-dependent increases 158 
(Table 2). Perfusion of the galanin antagonist alone failed 159 
to affect the protein concentration of the perfusate (data 160 
not shown). 161 
In the chronically denervated skin the permeability 162 
increasing effect of histamine was greatly augmented; the 163 
total protein content of the perfusate increased by 49±3% 164 
as compared to the control (Fig. 1, P < 0.05, n = 6). This 165 
enhanced response to histamine was not affected by 166 
coadministration of M35 (Fig. 1). However, in the chroni- 167 
Table 1 61 
Dose-dependent effect of histamine on the protein content of the skin 62 
perfusates 63 
Histamine Protein content* Percent increase 65 
(M-M) ( w 0 
Control 19.71iI . lS 68 
10 27.95+4.19» 41.81+21.26* 69 
100 39.02+5.76* 97.97+29.22* 70 
500 48.64+3.35* 146.78+16.98* 71 
1000 61.51 ±9.37* 212.07+47.53* a 
' Data represent the total protein content of skin perfusates collected for 74 
40 min during the administration of histamine at the concentrations 75 
indicated. 76 
*, Values are significantly different from the control and from each 77 
other, P< 0.05, n = 5 . 78 
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Table 2 
Dose-dependent effect of the galanin antagonist, M35 on the histamine-
induced changes in the protein concentration of skin perfusates 
Protein content1 Increase 
(H-g) (%) 
Control 20.91 ±1.29 
Histamine 48.64±3.35* 132.62± 16.02* 
+ 0.2 (JLM M35 54.05±2.61* 158.49± 12.48* 
+ 2 jlM M35 66.09±3.34* 216.07 ±15.97* 
+ 10 (JLM M35 79.43±8.07* 279.87±38.59* 
10 (xM M35 21.59±1.75 3.25±8.37 
" Data represent the total protein content of skin perfusates collected for 
40 min during the coadministration of histamine and M35. Histamine was 
used at a concentration of 500 p,M. 
*, Significantly different from the control, P < 0.05, n = 5 for each 
treatment group. 
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Fig. 1. Effect of the galanin antagonist M35 and of chronic cutaneous 
denervation on histamine-induced cutaneous plasma extravasation. Data 
represent changes in the total protein content of skin perfusates collected 
during the administration of histamine (500 p.M), M35 (10 p.M), or both. 
Open and shaded bars represent data obtained in the intact, innervated and 
in the denervated skin, respectively. *, Significantly different from 
control, P < 0.05, n - 6. For further details see text. 
cally denervated skin, administration of galanin (10 |±M) 
strongly inhibited the enhanced plasma leakage induced by 
histamine resulting in values similar to those obtained in 
the intact (innervated) skin ( / ' < 0 . 0 5 , n = 5). 
Histological examination of tissue samples obtained 
from skin sites injected with histamine and/or the galanin 
antagonist supported these findings (Fig. 2). In the inner-
vated skin, sites of histamine injections showed marked 
vascular labelling: small blood vessels displayed conspicu-
ous silver depositions in their walls, a characteristic 
histological feature of leaky venules [15-18]. Quantitative 
analysis revealed a significantly increased number of leaky 
blood vessels at sites of injections of the galanin antagonist 
and histamine as well as at sites of injections of histamine 
in the denervated skin (Fig. 2B and C and Table 3). 
Injection of the galanin antagonist on its own did not cause 
vascular labelling. Measurements of silver-labelled blood 
vessels revealed a significant increase in their diameters 
following the coadministration of histamine and M35 or 
after chronic cutaneous denervation (mean diameters of 
labelled vessels: histamine: 22.1 ±0.9, histamine plus M35: 
28.5±2.4, histamine plus denervation: 28.7±1.8 (xm). 
4. Discussion 
In recent years sensory nerves have been shown to 
contribute to the mechanism of a variety of vascular and 
inflammatory responses by the release of vasoactive sen-
sory neuropeptides [2,5-8]. In mammalian species this 
particular population of afferent nerves is characterized by 
their sensitivity to capsaicin [3,4,19] owing to the expres-
sion of a capsaicin receptor, the type 1 vanilloid receptor, 
VR1 [20]. Avian species are essentially insensitive to 
capsaicin [10] and probably do not express such receptors. 
The present findings indicate that sensitivity of primary 
sensory neurons to capsaicin is not essential with respect to 
their 'sensory efferent' or local regulatory function. Hence, 
elimination of cutaneous nerves by chronic denervation 
resulted in significant changes in the inflammatory re-
sponses to histamine. This effect may be attributed to an 
action on sensory nerves, since pretreatment of the animals 
with guanethidine, an adrenergic neuron blocking agent, 
failed to significantly affect cutaneous inflammatory re-
sponses (unpublished observations). These findings suggest 
that cutaneous afferent nerves may exert an inhibitory 
effect on vascular responses. 
Previous studies have shown that administration of a 
specific galanin antagonist largely augmented cutaneous 
vascular responses evoked by antidromic electrical stimu-
lation of cutaneous nerves or by direct application of 
chemical irritants onto the skin [11,12], Therefore, it has 
been concluded that, in the intact, innervated skin, galanin 
may inhibit inflammatory responses. It has been suggested 
that galanin, at least in part, may be of neurogenic origin, 
since immunohistochemical studies revealed that in the 
pigeon a large population of sensory ganglion cells contain 
galanin [21]. The involvement of galanin in these re-
sponses is further supported by the present findings 
showing that, in the denervated skin, administration of 
galanin significantly reduced the augmented response to 
histamine. 
Histamine may elicit its vascular permeability enhancing 
effect not only by a direct vascular action but also by an 
indirect action on sensory nerves. Thus, histamine has been 
shown to stimulate sensory nerve endings [22] and to 
release (proinflammatory) sensory neuropeptides from 
them [23], Therefore, the most likely explanation of the 
present results is that in the intact skin this 'neurogenic' 
effect of histamine is inhibited by a tonic release of 
galanin. In addition, histamine may also release galanin 
273 4 
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68 Fig. 2. Light microscopic photographs showing details of intact (A,B,D) and denervated (C) dorsal wing skin sites injected intracutaneously with histamine 
69 (A,C), with histamine and the galanin antagonist, M35 (B) or with Tyrode's solution (D). Leaky blood vessels situated mostly in the vicinity of feather 
70 follicles are characterized by the intense deposition of colloidal silver in their walls. Note the marked increase of histamine-induced vascular labelling in 
71 the denervated skin (C) and after the administration of M35 (B). There is no labelling after an injection of Tyrode's solution (D). Scale bar in (D) 
72 represents 100 p.m and applies for all microphotographs. 
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Table 3 
Quantitative histological evaluation of the effect of M35 and of chronic 
denervation on the histamine-induced increase in cutaneous vascular 
permeability 
Lengths of labelled blood vessels' 
(mm/mm2) 
Histamine 8.31 ±2.54 
Histamine 16.80±2.69* 
+ M35 
Histamine 14.25±2.80* 
+ denervation 
* Data represent the lengths of silver-labelled cutaneous blood vessels 
per unit surface area of the skin. Histamine and M35 were administered at 
concentrations of 500 p.M and 10 |iM, respectively. 
*, Significantly different from histamine, P < 0.05, n = 6. 
which may mask the effect or result in a diminished 
release of pro-inflammatory peptides from the same or 
from different nerves. The widespread presynaptic inhib-
itory effect of galanin on transmitter release [24] involving 
the inhibition of peptide release from sensory nerves 
[23,25,26] is in line with this suggestion. The findings 
showing a marked increase in the permeability enhancing 
effect of histamine in the denervated skin and, in par-
ticular, in the innervated skin following a coadministration 
of a galanin receptor antagonist also strongly support this 
notion. However, the possibility that galanin may affect 
vascular responses by a direct action on blood vessels 
cannot be excluded. Chronic cutaneous denervation, by a 
reduction of tissue galanin level, may lead to a suppression 
of the inhibitory effect of galanin on vascular permeability 
and, consequently to an enhancement of the permeability 
increasing effect of histamine. This is supported by our 
finding showing that, in the denervated skin, administration 
of galanin markedly reduced the increased permeability 
enhancing effect of histamine. A similar postjunctional 
inhibitory effect of galanin on vascular permeability has 
been suggested also in a previous study showing inhibition 
of substance P-induced plasma extravasation by exogenous 
galanin [27], 
Histological observations revealed that increase in the 
protein contents of skin perfusates following the coad-
ministration of histamine and M35 is associated with an 
increase in the lengths of silver-labelled cutaneous blood 
vessels. This may result either from recruitment of small 
blood vessels of similar type and/or from the involvement 
of topographically different segments of the vascular tree 
in the inflammatory response. This latter possibility is 
supported by the quantitative histological findings which 
demonstrated significant increases in the diameters of 
labelled blood vessels after both chronic denervation and 
coadministration of M35 and histamine. In addition, the 
histological findings also disclosed that increases in the 
protein concentration of the perfusates resulted from the 
escape of plasma proteins from the circulation due to 
enhanced vascular permeability. 
In conclusion, the present findings strongly indicate that 
galanin-containing nerves may fulfil a novel, inhibitory 
local regulatory or sensory-efferent function of cutaneous 
nerves. Further studies are needed to determine the factors 
which may influence and modify the release of peptides 
and/or other mediators from cutaneous nerves or non-
neural elements under physiological conditions. The find-
ings showing that galanin is the most abundant peptide 
among rat sensory nerve fibres [28] may indicate that 
galanin may be of significance in the modulation of 
vascular responses in mammalian species as well. 
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